The Federal Trade Commission (FTC) is taking an important step toward public transparency by evaluating whether children, parents, and families have been misled by radical gender ideology.
For too long, radical activists have pushed so-called “gender-affirming care” on vulnerable children — some as young as toddlers. These treatments carry significant and permanent risks, yet the interests standing to gain financially from their pain downplay the harm and overstate the benefit for industry profit.
Confused children are being placed on an irreversible medical path that includes puberty blockers, cross-sex hormones, and surgeries that cause sterilization and remove healthy body parts, putting physical development and mental health at risk. These procedures are marketed to families as safe, necessary, and reversible – claims that fail to disclose the harm and harsh reality that these experimental procedures are unforgiving if a child changes their mind. These aren’t compassionate treatments; they're irreversible experiments sold to families on false pretenses.
Despite these dangers, sex-rejecting procedures have grown into a billion-dollar industry, with many providers profiting directly from the same drugs and procedures they recommend. This raises serious ethical questions: Are parents being misled? Are the risks disclosed? Are the so-called “benefits” overstated?
Americans deserve to know the truth. It's time to put the care and well-being of children first. Submit your comment by September 26th to the Federal Trade Commission to demand transparency of so-called “gender-affirming care.”
You can personalize your comment by sharing examples of false data, advertisements, social media posts, disclosures, or empirical research that have harmed children and families.
More details on the request can be found here. The FTC also offers an option for confidential submissions, if you possess or are aware of sensitive information that provides evidence of fraud which the FTC may investigate. If you want to submit a confidential, non-public comment for consideration, please follow these instructions.